Showing 1 - 2 results of 2 for search 'Amal Salah Elhamaky', query time: 0.02s Refine Results
  1. 1
    Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial

    Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial by Moataz Maher Emara, Neamat Hamdy Elsawy, Kholoud M. Abdelaaty, Amal Salah Elhamaky, Naglaa Hamdi Eltahan

    Published 2022-08-01
    Get full text
    Article
  2. 2
    Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial

    Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial by Naglaa Hamdi Eltahan, Neamat Hamdy Elsawy, Kholoud M. Abdelaaty, Amal Salah Elhamaky, Ahmed H. Hassan, Moataz Maher Emara

    Published 2024-02-01
    Get full text
    Article

Search Tools: